These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2623252)

  • 1. [Pulmonary toxicity of amiodarone].
    Sevillano Martín C; Callol Sánchez L; Calderón Alvarez J; Moreno Muro M; Gómez de Terreros FJ
    Rev Clin Esp; 1989 Nov; 185(7):362-5. PubMed ID: 2623252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytologic changes in bronchoalveolar lavage in amiodarone treated patients].
    Jolly E; Belloti MS; Lowenstein J; Luna C; Avagnina A; Elsner B; Mazzei JA
    Medicina (B Aires); 1991; 51(1):19-25. PubMed ID: 1921687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary responses to amiodarone in hamsters: comparison of intratracheal and oral administrations.
    Blake TL; Reasor MJ
    Toxicol Appl Pharmacol; 1995 Apr; 131(2):325-31. PubMed ID: 7716773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone pulmonary toxicity: clinical and subclinical features.
    Adams PC; Gibson GJ; Morley AR; Wright AJ; Corris PA; Reid DS; Campbell RW
    Q J Med; 1986 May; 59(229):449-71. PubMed ID: 3763811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spectrometric and ultrastructural study of pneumopathy induced by amiodarone].
    Breton JL; Depierre A; Garnier G
    Ann Med Interne (Paris); 1985; 136(1):76-7. PubMed ID: 4003996
    [No Abstract]   [Full Text] [Related]  

  • 6. A characterization of amiodarone-induced pulmonary toxicity in F344 rats and identification of surfactant protein-D as a potential biomarker for the development of the toxicity.
    Taylor MD; Van Dyke K; Bowman LL; Miles PR; Hubbs AF; Mason RJ; Shannon K; Reasor MJ
    Toxicol Appl Pharmacol; 2000 Sep; 167(3):182-90. PubMed ID: 10986009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pneumopathies caused by hypersensitivity to amiodarone and associated nephropathies. Study by alveolar lavage].
    Caubarrère I; Bonan G; Venet A; Chebat J; Uzzan D; Gilbert J; Beaufils H
    Ann Med Interne (Paris); 1985; 136(4):311-5. PubMed ID: 4037586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pneumonitis and pulmonary fibrosis due to amiodarone. Report of 2 cases with optic and electronic microscopy].
    Lunardi W; Lopes EA; Kehde E; Vargas FS; Pereira Júnior W; Uip DE; Cukier A; Terra Filho M; Hernández EA; Duarte MI
    Arq Bras Cardiol; 1986 Jun; 46(6):415-9. PubMed ID: 3579634
    [No Abstract]   [Full Text] [Related]  

  • 9. Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis.
    Ohar JA; Jackson F; Dettenmeier PA; Bedrossian CW; Tricomi SM; Evans RG
    Chest; 1992 Oct; 102(4):999-1004. PubMed ID: 1395816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of amiodarone pulmonary toxicity.
    Kennedy JI
    Clin Chest Med; 1990 Mar; 11(1):119-29. PubMed ID: 2182273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial pneumopathy and low-dosage amiodarone.
    Pozzi E; Sada E; Luisetti M; De Rose V; Scelsi M
    Eur J Respir Dis; 1984 Nov; 65(8):620-2. PubMed ID: 6519218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoalveolar lavage cell data in amiodarone-associated pneumonitis. Evaluation in 22 patients.
    Akoun GM; Cadranel JL; Blanchette G; Milleron BJ; Mayaud CM
    Chest; 1991 May; 99(5):1177-82. PubMed ID: 1673380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis.
    Xaubet A; Roca J; Rodriguez-Roisin R; Herranz J; Marin A; Lomeña F; Montserrat JM; Agustí-Vidal A
    Respiration; 1987; 52(4):272-80. PubMed ID: 3438590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Steroid-refractory amiodarone-induced pulmonary fibrosis. Clinical features and morphology after an amiodarone-free interval of 3 months].
    Esinger W; Schleiffer T; Leinberger H; Hertrich F; Köhler G; Gröger C; Raute-Kreinsen U
    Dtsch Med Wochenschr; 1988 Oct; 113(42):1638-41. PubMed ID: 3181014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pneumonitis induced by amiodarone].
    Terra Filho M; Vargas FS; Cukier A; Teixeira LR; Pinto RM; Pileggi F
    Arq Bras Cardiol; 1989 Oct; 53(4):201-5. PubMed ID: 2483501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone pulmonary toxicity. Clinical, cytologic and ultrastructural findings.
    Stein B; Zaatari GS; Pine JR
    Acta Cytol; 1987; 31(3):357-61. PubMed ID: 3473872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects.
    Martin WJ; Standing JE
    J Pharmacol Exp Ther; 1988 Feb; 244(2):774-9. PubMed ID: 3346847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amiodarone: a new etiology of diffuse interstitial pneumopathy? Apropos of 2 personal cases and 10 cases from the literature].
    Vergnon JM; Wiesendanger T; Bellemin JP; Brune J
    Rev Mal Respir; 1984; 1(1):43-50. PubMed ID: 6463349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug pneumopathy. Early anatomo-pathologic study].
    Magar Y; Vaury P; Gacouin JC; Sauvaget J
    Therapie; 1984; 39(6):711-2. PubMed ID: 6531744
    [No Abstract]   [Full Text] [Related]  

  • 20. Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature.
    Coudert B; Bailly F; Lombard JN; Andre F; Camus P
    Chest; 1992 Oct; 102(4):1005-12. PubMed ID: 1395734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.